IRIS
MENNINI, FRANCESCO SAVERIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.556
EU - Europa 3.497
AS - Asia 1.929
SA - Sud America 228
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 5
Totale 32.244
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.505
IT - Italia 1.520
SG - Singapore 1.022
IE - Irlanda 461
DE - Germania 353
CN - Cina 314
UA - Ucraina 301
RU - Federazione Russa 213
BR - Brasile 192
HK - Hong Kong 177
GB - Regno Unito 143
SE - Svezia 128
FR - Francia 122
VN - Vietnam 96
KR - Corea 89
ID - Indonesia 76
FI - Finlandia 61
NL - Olanda 48
CA - Canada 38
BE - Belgio 30
IN - India 29
IR - Iran 29
AT - Austria 24
CH - Svizzera 22
PL - Polonia 19
TW - Taiwan 16
ES - Italia 13
AR - Argentina 11
JP - Giappone 10
PH - Filippine 10
PK - Pakistan 10
CO - Colombia 9
EU - Europa 9
IQ - Iraq 8
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
BD - Bangladesh 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
RO - Romania 6
ZA - Sudafrica 6
TR - Turchia 5
AU - Australia 4
GR - Grecia 4
MY - Malesia 4
UZ - Uzbekistan 4
AL - Albania 3
DK - Danimarca 3
DM - Dominica 3
JO - Giordania 3
KE - Kenya 3
MX - Messico 3
NO - Norvegia 3
OM - Oman 3
VE - Venezuela 3
BO - Bolivia 2
CL - Cile 2
HT - Haiti 2
HU - Ungheria 2
KG - Kirghizistan 2
MK - Macedonia 2
PY - Paraguay 2
TH - Thailandia 2
ZM - Zambia 2
AO - Angola 1
AZ - Azerbaigian 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
NA - Namibia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 32.244
Salva come PNG Salva come JPEG
Città #
Wilmington 7.137
Houston 6.880
Woodbridge 6.755
Fairfield 906
Singapore 666
Chandler 498
Ann Arbor 426
Ashburn 388
Dublin 384
Seattle 339
Rome 314
Cambridge 293
Medford 293
Jacksonville 256
New York 207
Dearborn 182
Hong Kong 174
Milan 168
Beijing 158
Santa Clara 158
Lawrence 136
Dong Ket 94
San Diego 86
Jakarta 75
Menlo Park 58
Moscow 55
The Dalles 38
Phoenix 34
Nuremberg 30
Catania 28
North Bergen 28
Redwood City 28
Verona 27
London 25
Mülheim 25
Seoul 25
Brussels 23
Nanjing 22
Turin 21
Naples 19
Florence 18
Norwalk 18
São Paulo 18
Toronto 18
Council Bluffs 16
Guangzhou 16
Napoli 16
Parma 16
Hangzhou 15
Los Angeles 15
Belo Horizonte 12
Boardman 12
Bologna 12
Creede 12
Falls Church 12
Kraków 12
Messina 12
Ottawa 12
Zurich 12
Monmouth Junction 11
Munich 11
Perugia 11
Taipei 11
University Park 11
Frankfurt am Main 10
Miami 10
Mountain View 10
Dallas 9
Amsterdam 8
Bangalore 8
Brescia 8
Chengdu 8
Genoa 8
Hefei 8
Kunming 8
Redmond 8
Saint Petersburg 8
San Francisco 8
Shanghai 8
Tehran 8
Zhengzhou 8
Palermo 7
Pomezia 7
Rho 7
San Mateo 7
Chicago 6
Helsinki 6
Lisbon 6
Manila 6
Roebling 6
Vienna 6
Bari 5
Campobasso 5
Cattolica 5
Charsadda 5
Duncan 5
Galway 5
Genova 5
Goiânia 5
Jinan 5
Totale 28.040
Salva come PNG Salva come JPEG
Nome #
Extending influenza vaccination to individuals aged 50-64: a budget impact analysis 511
Strategie e performance nel mercato farmaceutico italiano: un'analisi empirica 509
Economic Burden of Human Papillomavirus-Related Diseases in Italy 442
General disease costing principles 439
A one-year retrospective economic evaluation of botulinum toxin type A treatment of chronic tension headache 433
Economic effects of treatment of chronic kidney disease with low-protein diet 433
A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache 431
Governance of preventive health intervention and on time verification of its efficiency: the GIOVE study 431
Health Utilities Lost and Risk Factors Associated With HPV-induced Diseases in Men and Women: The HPV Italian Collaborative Study Group 425
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab. 409
The perception of corruption in health: AutoCM methods for an international comparison 408
Scenari e strategie nel settore farmaceutico 407
Rapid responses to: Letter to the Editor, by L. Garattini and G. Casadei [Vaccine 27 (38) (20 August 2009) 5171] 402
Cost-effectiveness analysis for the treatment of chronic kidney disease with low-protein diet 400
Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory 396
Towards the eradication of HPV infection through universal specific vaccination 394
A One-Year Economic Evaluation of Botulinum Toxin Type A Treatment of Chronic Tension-type Headaches: Part II 392
The new perspectives of italian national health service 391
Treatment plan comparison in acute and chronic respiratory tract diseases: an observational study of doxophylline vs. theophylline 389
Improving care through health economics analyses: cost of illness and headache 387
Hospital costs incurred by the Italian national health service for invasive cervical cancer 384
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 382
Rapporto CEIS-Sanità 2005: sette parole chiave del SSN 380
Pilot evaluation of indirect costs and the impact of bipolar disorder type I 378
Oral vs injection therapy in the treatment of metastatic colorectal cancer. a cost minimization analysis in a public hospital of the lazio region [Terapia orale vs terapia infusionale nel trattamento del cancro del colon retto localmente avanzato o avanzato analisi di minimizzazione dei costi presso una struttura ospedaliera della regione lazio] 378
Health and economic impact associated with a quadrivalent HPV vaccine in Italy 377
Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology: The BEST II Study 371
Rapporto CEIS-Sanità 2003: bisogni, risorse e nuove strategie 365
Rapporto CEIS-Sanità 2004: sostenibilità, equità e ricerca dell'efficienza 365
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional healthcare providers 361
Healthcare resource utilization among patients with relapsed multiple myeloma in the UK, France, and Italy 361
Population-based frequency assessment of HPV-induced lesions in patients with borderline Pap tests in the Emilia-Romagna Region: the PATER study 360
Public health value of universal HPV vaccination 357
Rapporto CEIS-Sanità 2007: responsabilità, autonomia, sussidiarietà, integrazione, valutazione, empowerment: 6 "nuove" parole chiave per il futuro del SSN 355
Cost of poor adherence to anti-hypertensive therapy in five European countries 354
The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility. 345
The Welfare States in a United Europe 343
Economic burden of schizophrenia in Italy: a probabilistic cost of illness analysis 343
Anti-HPV vaccination in Italy: a review of recent economic data for Italy 342
Criteri per l'allocazione regionale delle risorse per la sanità: riflessioni sul caso italiano 342
Economic evaluation of spondyloarthritis: Economic impact of diagnostic delay in Italy 342
Joint Procurement and the EU perspective. In Law and Economics of Public Procurement reforms 334
Equità e fairness del servizio sanitario nazionale italiano 333
Improving care through health economics analyses: cost of illness and headache (general disease costing principles) 331
Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients 331
The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation 329
The economic value of vaccinations: a systematic review of Italian economic evaluations and HTA reports. 328
Does regional belonging explain the similarities in the expenditure determinants of Italian healthcare deliveries?: An approach based on Artificial Neural Networks 325
Primary Biliary Cholangitis: advances in management and treatment of the disease 324
Il settore industriale sanitario in Italia 321
Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study 321
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study 320
Dinamiche e determinanti del settore farmaceutico in Europa 314
Human papillomavirus 9-valent vaccine for cancer prevention: A systematic review of the available evidence 308
Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study. [Costi diretti e indiretti associati a malattie allergiche respiratorie in Italia. Uno studio probabilistico di cost of illness] 305
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada 305
Time trade-off procedure for measuring health utilities loss with human papillomavirus–induced diseases: a multicenter, retrospective, observational pilot study in Italy 304
Economic burden of diverticular disease: An observational analysis based on real world data from an Italian region 302
Fraud and Corruption in Healthcare: Recognizing Such Phenomena to Combat Them. 297
A novel method to value real options in health care: The case of a multicohort human papillomavirus vaccination strategy 291
Dimensioni e tendenze del mercato farmaceutico in Italia (1980/1997) 289
Health policy model: Long-term Predictive results associated with the management of hepatitis C virus-induced diseases in Italy 289
PDB51. Direct and indirect cost of diabetes in italy: A prevalence probabilistic approach 285
Il settore industriale farmaceutico italiano 279
Economic impact of biosimilar drugs in Italy: past, present and future of infliximab and etanerceptt 273
Analisi di impatto di budget di pasireotide in pazienti con Acromegalia nella prospettiva del Servizio Sanitario Nazionale 266
null 263
Economics of Headache 261
Early treatment in HIV patients: a cost–utility analysis from the Italian perspective 261
Introduzione 259
Strategie e performance delle grandi aziende farmaceutiche in Italia (1979-2001) 256
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 249
Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy 236
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 228
Erratum to: Artificial neural networks and their potentialities in analyzing budget health data: an application for Italy of what-if theory 225
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy 224
The economic impact of biosimilars in Italy: a scenario analysis 222
Screening strategies for Hepatitis C Virus elimination in Italy 215
Economic burden of HPV9-related diseases: a real-world cost analysis from Italy 209
Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. Human menopausal gonadotropin for women undergoing IVF 207
Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer 205
Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma 203
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 201
Budget Impact Analysis della gestione dell'agitazione psicomotoria con loxapina inalatoria in Italia. 194
HPV Vaccination Concepts in the Reality of Today 186
Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of 3 European Countries 182
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 174
La corruzione in sanità: i nuovi strumenti per individuarla e contrastarla 170
Economic burden of disease of uncontrolled acromegalic patients: the acromegaly Italian collaborative study group 160
Analisi di Budget Impact su modelli di acquisto e gestione degli ausili per l’incontinenza urinaria a confronto 158
Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy 156
Budget Impact Analysis of Dalbavancin in the Treatment of Acute Bacterial Skin and Skin Structure Infections in Three European Countries 155
Invecchiamento della popolazione e sostenibilità del SSN:il ruolo della Health Technology Assessment (HTA) per la valutazione tecnica, economica ed organizzativa della Sanità del futuro 154
Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective 151
PIN79 - ECONOMIC CONSEQUENCES OF ANTI-HCV ANTIVIRAL TREATMENT INVESTMENT FROM THE NHS PERSPECTIVE: A REAL-WORLD-BASED ANALYSIS FROM PITER DATA 148
Estimation of the number of HCV-positive patients in Italy 145
The burden of atopic dermatitis in adults in Italy 139
Burden economico della neuropatia ottica ereditaria di Leber (LHON) in Italia: stima dei costi indiretti e diretti a carico del paziente. 133
Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate 118
Osteoporosis: Economic Burden of Disease in Italy 114
Totale 30.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.780
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.745 0 0 0 0 0 0 0 0 0 671 560 514
2020/20215.345 506 525 576 553 751 611 628 491 142 145 235 182
2021/20221.594 77 129 139 88 71 87 148 143 94 82 147 389
2022/20231.701 176 111 51 198 148 403 163 104 142 33 118 54
2023/2024946 87 44 66 31 79 226 66 50 61 52 45 139
2024/20252.769 117 831 348 228 106 265 214 172 308 180 0 0
Totale 32.704